share_log

Smart for Life | 10-K: FY2023 Annual Report

Smart for Life | 10-K: FY2023 Annual Report

Smart for Life | 10-K：2023財年年報
美股SEC公告 ·  2024/09/21 04:57

Moomoo AI 已提取核心訊息

Smart for Life reported total revenue of $8.2 million for fiscal year 2023, down from $15.9 million in 2022, primarily due to cash constraints affecting raw material purchases and production capacity. The company recorded a net loss of $22.7 million compared to $30.0 million in the prior year, while gross profit margin improved to 37.6% from 32.0%.Management has implemented significant restructuring initiatives including staff reductions, the sale of BSNM manufacturing facility, and divestiture of Ceautamed's assets into First Health FL LLC for a 49% ownership stake. The company also executed multiple debt-to-equity conversions totaling $15.3 million to strengthen its balance sheet and completed warrant exercises generating $7.3 million in proceeds.Looking ahead, Smart for Life is pursuing strategic acquisitions including the pending purchase of Purely Optimal Nutrition for $12.0 million. The company secured new financing arrangements including a $500,000 credit facility with Abbsi LLC and continues to focus on operational efficiencies while expanding its nutraceutical product portfolio through both organic growth and M&A activities.
Smart for Life reported total revenue of $8.2 million for fiscal year 2023, down from $15.9 million in 2022, primarily due to cash constraints affecting raw material purchases and production capacity. The company recorded a net loss of $22.7 million compared to $30.0 million in the prior year, while gross profit margin improved to 37.6% from 32.0%.Management has implemented significant restructuring initiatives including staff reductions, the sale of BSNM manufacturing facility, and divestiture of Ceautamed's assets into First Health FL LLC for a 49% ownership stake. The company also executed multiple debt-to-equity conversions totaling $15.3 million to strengthen its balance sheet and completed warrant exercises generating $7.3 million in proceeds.Looking ahead, Smart for Life is pursuing strategic acquisitions including the pending purchase of Purely Optimal Nutrition for $12.0 million. The company secured new financing arrangements including a $500,000 credit facility with Abbsi LLC and continues to focus on operational efficiencies while expanding its nutraceutical product portfolio through both organic growth and M&A activities.
Smart for Life報告了2023財年的總營業收入爲820萬美元，較2022年的1590萬美元下降，主要是由於現金限制影響了原材料採購和生產能力。公司記錄的淨虧損爲2270萬美元，而去年爲3000萬美元，毛利潤率從32.0%提高到37.6%。管理層已實施重組措施，包括裁員、出售BSNm製造設施，以及將Ceautamed的資產剝離給First Health FL LLC以獲取49%的股份。公司還進行了多項債轉股，總計1530萬美元，以增強其資產負債表，並完成了募股權的行使，產生了730萬美元的收益。展望未來，Smart for Life正在追求戰略收購，包括即將以1200萬美元收購Purely Optimal Nutrition。公司獲得了新的融資安排，包括與Abbsi LLC的50萬美元信貸額度，並繼續專注於運營效率，同時通過有機增長和併購活動擴大其營養保健產品組合。
Smart for Life報告了2023財年的總營業收入爲820萬美元，較2022年的1590萬美元下降，主要是由於現金限制影響了原材料採購和生產能力。公司記錄的淨虧損爲2270萬美元，而去年爲3000萬美元，毛利潤率從32.0%提高到37.6%。管理層已實施重組措施，包括裁員、出售BSNm製造設施，以及將Ceautamed的資產剝離給First Health FL LLC以獲取49%的股份。公司還進行了多項債轉股，總計1530萬美元，以增強其資產負債表，並完成了募股權的行使，產生了730萬美元的收益。展望未來，Smart for Life正在追求戰略收購，包括即將以1200萬美元收購Purely Optimal Nutrition。公司獲得了新的融資安排，包括與Abbsi LLC的50萬美元信貸額度，並繼續專注於運營效率，同時通過有機增長和併購活動擴大其營養保健產品組合。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

獨立文件2  查看翻譯

獨立文件3  查看翻譯

獨立文件4  查看翻譯

獨立文件5  查看翻譯

獨立文件6  查看翻譯

獨立文件7  查看翻譯

獨立文件8  查看翻譯

獨立文件9  查看翻譯

獨立文件10  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    相關股票 相關股票
    代碼 迷你走勢 最新價
    英偉達
    NVDA
    -- 138.850
    特斯拉
    TSLA
    -- 355.840
    阿里巴巴
    BABA
    -- 124.730
    英特爾
    INTC
    -- 23.600
    Tempus AI
    TEM
    -- 89.440
    解鎖完整榜單
    重估中國資產
    繼中國開創性的DeepSeek技術推出之後，華爾街大行重估對中國市場的投資前景。
    熱門討論
    科技巨頭財報季如火如荼，英偉達壓軸會表現如何？
    週四， $亞馬遜 (AMZN.US)$ 該公司報告第四季度調整後每股收益爲1.86美元，高於1.50美元的預期，營業收入爲1877.9亿美元，高於1873.2亿美元的預期。公司預測下一季度營收將低於華爾街的預期，預計本季度最多爲1550亿美元，而分析師們希望達到1580亿美元。 展开
    亞馬遜收益預覽：通過猜測開盤價格獲得獎勵！